Biohit Oyj B (BIOBV)

Currency in EUR
2.840
-0.040(-1.39%)
Closed·
BIOBV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BIOBV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8402.900
52 wk Range
2.0804.350
Key Statistics
Prev. Close
2.88
Open
2.88
Day's Range
2.84-2.9
52 wk Range
2.08-4.35
Volume
4.63K
Average Volume (3m)
11.49K
1-Year Change
29.15%
Book Value / Share
0.86
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOBV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.200
Upside
+12.68%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Biohit Oyj B Company Profile

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; BIOHIT Active B12, a test for measuring the concentration of total vitamin-B12 in the serum; BIOHIT Total 25OH Vitamin D, a test for determination of 25-hydroxyvitamin D2 and D3; and BIOHIT Calprotectin test, a quantitative test that provides a reliable differentiation between inflammatory bowel diseases and irritable bowel syndrome. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; Gluten Immunogenic Peptides test; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. The company provides acetaldehyde-binding products, such as Acetium capsules for protection of stomach; Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. It also offers BIOHIT FAEX for the collection and handling of stool samples; and GP Reader NT, an automated instrument for the quantitative determination of various analytes in human samples, such as whole blood, plasma, or fecal samples by measuring fluorescence signals from lateral flow test cassettes. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.

Employees
49
Market
Finland

Compare BIOBV to Peers and Sector

Metrics to compare
BIOBV
Peers
Sector
Relationship
P/E Ratio
19.1x−2.0x−0.5x
PEG Ratio
0.52−0.050.00
Price/Book
3.3x2.2x2.6x
Price / LTM Sales
3.0x3.2x3.3x
Upside (Analyst Target)
12.7%49.3%42.9%
Fair Value Upside
Unlock7.7%6.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.200
(+12.68% Upside)

Earnings

Latest Release
Mar 19, 2025
EPS / Forecast
0.09 / 0.06
Revenue / Forecast
6.88M / --
EPS Revisions
Last 90 days

BIOBV Income Statement

FAQ

What Stock Exchange Does Biohit Oyj B Trade On?

Biohit Oyj B is listed and trades on the Helsinki Stock Exchange stock exchange.

What Is the Stock Symbol for Biohit Oyj B?

The stock symbol for Biohit Oyj B is "BIOBV."

What Is the Biohit Oyj B Market Cap?

As of today, Biohit Oyj B market cap is 43.12M.

What Is Biohit Oyj B's Earnings Per Share (TTM)?

The Biohit Oyj B EPS (TTM) is 0.15.

From a Technical Analysis Perspective, Is BIOBV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biohit Oyj B Stock Split?

Biohit Oyj B has split 0 times.

How Many Employees Does Biohit Oyj B Have?

Biohit Oyj B has 49 employees.

What is the current trading status of Biohit Oyj B (BIOBV)?

As of 11 Aug 2025, Biohit Oyj B (BIOBV) is trading at a price of 2.84, with a previous close of 2.88. The stock has fluctuated within a day range of 2.84 to 2.90, while its 52-week range spans from 2.08 to 4.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.